Toggle Offcanvas
...
 
Rivaroxaban Tenders

Rivaroxaban Tenders

View Rivaroxaban tenders, RFPs and contracts. Bid on readily available Rivaroxaban tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Rivaroxaban tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Rivaroxaban.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Rivaroxaban market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Rivaroxaban tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

33 Live Notices for Rivaroxaban Tenders

Showing 1 to 20

The Object Of Purchase Is Other/Other Medicines In Accordance With Paragraph 1.2 (Price Table - Annex N1).
country Georgia
posting date17 May 2025
deadline30 May 2025
The Object Of Purchase Is Other/Other Medicines In Accordance With Paragraph 1.2 (Price Table - Annex N1).
country Georgia
posting date16 May 2025
deadline27 May 2025
37,000 Com. They Were Rivaling 10 Mg. Supervision Of Regional Pharmacy Peace
country Bolivia
posting date14 May 2025
deadline27 May 2025
Acquisition Various Medications. Quote Only Online According To The Particular Specifications.
country Uruguay
posting date13 May 2025
deadline21 May 2025
Item 1 - Rivaroxaban (micronised) 15mg Tablets Item 2 - Rivaroxaban (micronised) 20mg Tablets
country Singapore
posting date12 May 2025
deadline30 May 2025
Item 1 - Rivaroxaban (micronised) 15mg Tablets Item 2 - Rivaroxaban (micronised) 20mg Tablets
country Singapore
posting date10 May 2025
deadline30 May 2025
Delivery Of Drugs
country Poland
posting date30 Apr 2025
deadline30 May 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Rivaroxaban (Atc Code According To Who: B01Af01)
country Germany
posting date23 Jan 2025
deadline31 May 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Rivaroxaban (Atc Code According To Who: B01Af01)
country Germany
posting date23 Jan 2025
deadline31 May 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open-House Model For The Active Ingredient Rivaroxaban (Atc Code According To Who: B01Af01)
country Germany
posting date23 Jan 2025
deadline31 May 2025
Mspas No. 2024-Roo-C196, Acquisition Of Rivaroxaban, For The Roosevelt Hospital
country Guatemala
posting date30 Sep 2024
deadline23 May 2025
Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form)
country Germany
posting date22 May 2024
deadline30 Apr 2026
Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - In All Potencies Except 2.5 Mg Per Divided Oral Dosage Form)
country Germany
posting date22 May 2024
deadline30 Apr 2026
Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form)
country Germany
posting date22 May 2024
deadline30 Apr 2026
Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form)
country Germany
posting date22 May 2024
deadline30 Apr 2026
Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - In All Potencies Except 2.5 Mg Per Divided Oral Dosage Form)
country Germany
posting date22 May 2024
deadline30 Apr 2026
Open House Discount Agreements 2024-04 - Rivaroxaban
country Germany
posting date11 Mar 2024
deadline30 Apr 2026
Open House Discount Agreements 2024-04 - Rivaroxaban
country Germany
posting date22 Jul 2024
deadline30 Apr 2026
2025 Yeel April Apriy Rivaroxaban
country Uzbekistan
posting date18 Apr 2025
deadline18 Apr 2026
Rivaroxaban - So17056915 - 24.03.2025
country Uzbekistan
posting date25 Mar 2025
deadline24 Mar 2026

Share Share this page